Geoffrey Dow
Gründer bei 60 DEGREES PHARMACEUTICALS, INC.
Vermögen: 222 687 $ am 31.05.2024
Profil
Geoffrey S.
Dow is the founder of 60 Pharmaceuticals LLC and 60 Degrees Pharmaceuticals, Inc., both founded in 2010.
He holds the titles of President, Chief Executive Officer, and Director at both companies.
Dr. Dow has an MBA from the University of Maryland, which was conferred in 2012.
He also has a doctorate degree from Murdoch University, conferred in 2000, and an undergraduate degree from Murdoch University, conferred in 1994.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.05.2024 | 762 625 ( 6,28% ) | 222 687 $ | 31.05.2024 |
Aktive Positionen von Geoffrey Dow
| Unternehmen | Position | Beginn |
|---|---|---|
| 60 DEGREES PHARMACEUTICALS, INC. | Gründer | 09.09.2010 |
60 Pharmaceuticals LLC
 60 Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of 60 Degrees Pharmaceuticals, Inc., 60 Pharmaceuticals LLC is an American company that develops and distributes drugs for tropical diseases. The company is based in Washington. The company was founded by Geoffrey S. Dow. Geoffrey S. Dow has been the CEO since incorporation. | Gründer | 01.01.2010 |
Ausbildung von Geoffrey Dow
| Murdoch University | Undergraduate Degree |
| University of Maryland | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
60 Pharmaceuticals LLC
60 Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of 60 Degrees Pharmaceuticals, Inc., 60 Pharmaceuticals LLC is an American company that develops and distributes drugs for tropical diseases. The company is based in Washington. The company was founded by Geoffrey S. Dow. Geoffrey S. Dow has been the CEO since incorporation. | Health Technology |
| 60 Degrees Pharmaceuticals, Inc. |
